Dr. Reddy's Laboratories slides Friday, underperforms market
Dr. Reddy's Laboratories Ltd. closed 18.89% below its 52-week high of 1,420.20 rupees, which the company reached on August ...
Reuters22d
Dr Reddy's Laboratories Ltd
Earnings worries yank Indian shares to third week of losses January 24, 2025 Shares of Dr Reddy's Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine months ...
The Motley Fool29d
Dr. Reddy's Laboratories (NYSE: RDY)
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active ...
Allspring Global Investments Holdings LLC Acquires 427,573 Shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY)
Allspring Global Investments Holdings LLC grew its holdings in Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by ...
Business Insider26d
Barclays Reaffirms Their Buy Rating on Dr Reddy’s Laboratories (RDY)
Barclays analyst Balaji Prasad maintained a Buy rating on Dr Reddy’s Laboratories (RDY – Research Report) today and set a price target of $17.00. The company’s shares closed last Friday at ...